article thumbnail

DEA & SAMHSA Issue Temporary Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Substances Prescribing Beyond the Termination of COVID-19 PHE

Hall Render

Notably, the Temporary Rule, which can be accessed here , extends the COVID-19 PHE telemedicine flexibilities (hereinafter, “telemedicine flexibilities”) for six months following the end of the PHE (through November 11, 2023).

article thumbnail

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps 

Bill of Health

With support from the Foundation for Opioid Response Efforts (FORE), public health law experts from Indiana University McKinney School of Law and the Temple University Center for Public Health Law Research at the Beasley School of Law recently embarked on a systematic review of U.S. Code § 1701 et seq.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Payor-Led Initiatives to Strengthen Mental Health Resources

Healthcare Law Blog

While digital health support tools provide essential supplemental care, payors continue to seek to address the indispensible need for licensed practitioners to provide mental health support to the growing number of patients in need of mental health care. 21, 2023). [5] November 2022. [2] 5] Bellon, J., PhD, Quinlan, C.,

article thumbnail

The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Health Law Advisor

Both the proposed rules related to telemedicine prescribing of Schedule III-V non-narcotic controlled substances, and the separate proposed rules related to telemedicine prescribing of buprenorphine, were published in the Federal Register on March 1, 2023. 21 U.S.C. § 802(17).

article thumbnail

Bonus Features – May 14, 2023 – Only 16% of organizations are using data to define clinical best practices, 84% of orgs hit with ransomware attacks lose revenue, and more

Healthcare IT Today

News In a temporary rule, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) extended telemedicine flexibilities for prescribing controlled medications for six months following the end of the public health emergency, through November 11.

article thumbnail

Medical Device Cybersecurity Provisions Included in Omnibus Appropriations Bill

HIPAA Journal

trillion omnibus appropriations bill has been released by the House and Senate Appropriations Committees which, if passed, will ensure that the government remains funded until September 30, 2023. The bill must be signed by the president on Friday this week, when government funding is set to expire. The text of a $1.7

FDA 106
article thumbnail

HIPAA Updates and HIPAA Changes in 2023

HIPAA Journal

Updates to HIPAA are long overdue but steps were finally made to update HIPAA in December 2020, when the HHS issued a notice of Proposed Rulemaking that detailed several proposed changes to the HIPAA Privacy Rule, and a Final Rule is now due which will likely see those HIPAA changes implemented in 2023. HIPAA Changes in 2023.

HIPAA 113